The Division of Hematology/Oncology offers expertise in the diagnosis and treatment of a broad spectrum of blood disorders and malignant diseases. The Hemology/Oncology faculty participate in specialized patient care and research programs in the areas of solid tumors, hematologic malignancies, thrombosis, bleeding disorders, sickle cell anemia, and bone marrow transplantation. In association with other members of the UNC Lineberger Comprehensive Cancer Center, specialized interdisciplinary oncology clinics and conferences are held weekly in the areas of breast cancer, thoracic, gastrointestinal, genitourinary, sarcoma, neuro-oncology, melanoma, and head and neck malignancies. Centers which are central to implementing the patient care and research missions of the Division include the Lineberger Comprehensive Cancer Center, one of the foremost cancer research centers in the country, and the nationally recognized Hemostasis and Thrombosis, Hemophilia, and Sickle Cell Centers.

Hematology & Oncology News

  • Nigel-Mackman-high-res.jpg

    Key, Mackman, Publish Research in the Journals Blood and Nature Reviews Drug Discovery

    Nigel Key, MD, the Harold R. Roberts Distinguished Professor of Medicine and Pathology and director of the UNC Blood Research Center published a study that identifies the intrinsic coagulation pathway as a potential target to prevent thrombotic and inflammatory complications after RBC transfusion. The article “Red blood cell microvesicles activate the contact system, leading to … Continued

  • stephan-moll

    Moll Announces Reintroduction of Clot Connect

    Stephan Moll, MD, professor of medicine in the division of hematology and oncology and member of the UNC Blood Research Center, announces the reintroduction of Clot Connect, a public service clearinghouse for clinically relevant information on thrombosis, thrombophilia, and anticoagulation information for patients and health care professionals. Established in 2010, the resource was created for … Continued

  • Rose Receives NCI Grant to Study Entinostat Combined With Immune Checkpoint Inhibition in Urothelial Cancer

    Tracy Rose, MD, MPH, assistant professor of medicine in the division of hematology and oncology and member of the UNC Lineberger Comprehensive Cancer Center, received a National Cancer Institute K08 grant “Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer.” This study uses a window … Continued

More Hematology & Oncology News